COVID-19 Infection
Comparative Study of COVID-19 Infection in Renal Transplant Recipients and Non Transplant Recipients
1 other identifier
observational
610
1 country
1
Brief Summary
Post-transplant patients with COVID-19 infection who attended Shenzhen No. 3 Hospital from December 2022 to February 2023, and enrolled the general population with COVID-19 infection who were hospitalized during the same period, matched by age and gender.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 24, 2023
CompletedFirst Posted
Study publicly available on registry
July 3, 2023
CompletedStudy Start
First participant enrolled
July 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2023
CompletedJuly 3, 2023
June 1, 2023
5 days
June 24, 2023
June 27, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
ICU admission or death
patients have ICU admission or death
through study completion, an average of 1 month
Study Arms (2)
Kidney Transplant Recipients Group (KTR)
Non-Kidney Transplant Recipients Group（NKTR）
Interventions
Patients with different diagnoses will get different treatment options
Eligibility Criteria
post-transplant patients with COVID-19 infection who attended Shenzhen No. 3 Hospital from December 2022 to February 2023, and enrolled the general population with COVID-19 infection who were hospitalized during the same period, matched by age and gender.
You may qualify if:
- Confirmed novel coronavirus infection between December 2022 to February 2023,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tianjin First Central Hospitallead
- Shenzhen Third People's Hospitalcollaborator
Study Sites (1)
yingxin Fu
Shenzhen, Guangdong, 518000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of department
Study Record Dates
First Submitted
June 24, 2023
First Posted
July 3, 2023
Study Start
July 25, 2023
Primary Completion
July 30, 2023
Study Completion
July 30, 2023
Last Updated
July 3, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share